BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37421787)

  • 1. Daily physical activity monitoring in older adults with metastatic prostate cancer on active treatment: Feasibility and associations with toxicity.
    Feng G; Parthipan M; Breunis H; Timilshina N; Soto-Perez-de-Celis E; Mina DS; Emmenegger U; Finelli A; Krzyzanowska MK; Clarke H; Puts M; Alibhai SMH
    J Geriatr Oncol; 2023 Sep; 14(7):101576. PubMed ID: 37421787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility and acceptability of remote symptom monitoring (RSM) in older adults during treatment for metastatic prostate cancer.
    Feng G; Parthipan M; Breunis H; Puts M; Emmenegger U; Timilshina N; Hansen AR; Finelli A; Krzyzanowska MK; Matthew A; Clarke H; Mina DS; Soto-Perez-de-Celis E; Tomlinson G; Alibhai SMH
    J Geriatr Oncol; 2023 Apr; 14(3):101469. PubMed ID: 36917921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding the incidence, duration, and severity of symptoms through daily symptom monitoring among frail and non-frail older patients receiving metastatic prostate cancer treatments.
    Parthipan M; Feng G; Breunis H; Timilshina N; Emmenegger U; Hansen A; Tomlinson G; Matthew A; Clarke H; Santa Mina D; Soto-Perez-de-Celis E; Puts M; Alibhai SMH
    J Geriatr Oncol; 2024 Apr; 15(3):101720. PubMed ID: 38350343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symptom experiences of older adults during treatment for metastatic prostate cancer: A qualitative investigation.
    Parthipan M; Feng G; Toledano N; Donison V; Breunis H; Sudharshan A; Emmenegger U; Finelli A; Warde P; Soto-Perez-de-Celis E; Krzyzanowska M; Matthew A; Clarke H; Mina DS; Alibhai SMH; Puts M
    J Geriatr Oncol; 2023 Jan; 14(1):101397. PubMed ID: 36988104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of frailty in modifying physical function and quality of life over time in older men with metastatic castration-resistant prostate cancer.
    Kim VS; Yang H; Timilshina N; Breunis H; Emmenegger U; Gregg R; Hansen AR; Tomlinson G; Alibhai SMH
    J Geriatr Oncol; 2023 Mar; 14(2):101417. PubMed ID: 36682218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of treatment on elder-relevant physical function and quality of life outcomes in older adults with metastatic castration-resistant prostate cancer.
    Yang H; Kim VS; Timilshina N; Breunis H; Emmenegger U; Gregg R; Hansen A; Tomlinson G; Alibhai SMH
    J Geriatr Oncol; 2023 Jan; 14(1):101395. PubMed ID: 36988103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Chemotherapy, Enzalutamide, Abiraterone, and Radium 223 With Cognitive Function in Older Men With Metastatic Castration-Resistant Prostate Cancer.
    Alibhai SMH; Breunis H; Feng G; Timilshina N; Hansen A; Warde P; Gregg R; Joshua A; Fleshner N; Tomlinson G; Emmenegger U
    JAMA Netw Open; 2021 Jul; 4(7):e2114694. PubMed ID: 34213559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pilot study of an accelerometer-equipped smartphone to monitor older adults with cancer receiving chemotherapy in Mexico.
    Soto-Perez-De-Celis E; Kim H; Rojo-Castillo MP; Sun CL; Chavarri-Guerra Y; Navarrete-Reyes AP; Waisman JR; Avila-Funes JA; Aguayo Á; Hurria A
    J Geriatr Oncol; 2018 Mar; 9(2):145-151. PubMed ID: 29017891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radium-223 and concomitant therapies in patients with metastatic castration-resistant prostate cancer: an international, early access, open-label, single-arm phase 3b trial.
    Saad F; Carles J; Gillessen S; Heidenreich A; Heinrich D; Gratt J; Lévy J; Miller K; Nilsson S; Petrenciuc O; Tucci M; Wirth M; Federhofer J; O'Sullivan JM;
    Lancet Oncol; 2016 Sep; 17(9):1306-16. PubMed ID: 27473888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of digital physical activity interventions on daily step count: a randomised controlled crossover substudy of the MyHeart Counts Cardiovascular Health Study.
    Shcherbina A; Hershman SG; Lazzeroni L; King AC; O'Sullivan JW; Hekler E; Moayedi Y; Pavlovic A; Waggott D; Sharma A; Yeung A; Christle JW; Wheeler MT; McConnell MV; Harrington RA; Ashley EA
    Lancet Digit Health; 2019 Nov; 1(7):e344-e352. PubMed ID: 33323209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of life in patients with metastatic prostate cancer following treatment with cabazitaxel versus abiraterone or enzalutamide (CARD): an analysis of a randomised, multicentre, open-label, phase 4 study.
    Fizazi K; Kramer G; Eymard JC; Sternberg CN; de Bono J; Castellano D; Tombal B; Wülfing C; Liontos M; Carles J; Iacovelli R; Melichar B; Sverrisdóttir Á; Theodore C; Feyerabend S; Helissey C; Oudard S; Facchini G; Poole EM; Ozatilgan A; Geffriaud-Ricouard C; Bensfia S; de Wit R
    Lancet Oncol; 2020 Nov; 21(11):1513-1525. PubMed ID: 32926841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the Feasibility and Usability of Smartphones for Monitoring Physical Activity in Orthopedic Patients: Prospective Observational Study.
    Ghaffari A; Kildahl Lauritsen RE; Christensen M; Rolighed Thomsen T; Mahapatra H; Heck R; Kold S; Rahbek O
    JMIR Mhealth Uhealth; 2023 Jul; 11():e44442. PubMed ID: 37283228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical Activity Monitoring Using a Fitbit Device in Ischemic Stroke Patients: Prospective Cohort Feasibility Study.
    Katzan I; Schuster A; Kinzy T
    JMIR Mhealth Uhealth; 2021 Jan; 9(1):e14494. PubMed ID: 33464213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A dose response relationship between accelerometer assessed daily steps and depressive symptoms in older adults: a two-year cohort study.
    Hsueh MC; Stubbs B; Lai YJ; Sun CK; Chen LJ; Ku PW
    Age Ageing; 2021 Feb; 50(2):519-526. PubMed ID: 32980870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gamified Text Messaging Contingent on Device-Measured Steps: Randomized Feasibility Study of a Physical Activity Intervention for Cancer Survivors.
    Robertson MC; Lyons EJ; Liao Y; Baum ML; Basen-Engquist KM
    JMIR Mhealth Uhealth; 2020 Nov; 8(11):e18364. PubMed ID: 33231551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linking physical activity to personal values: feasibility and acceptability randomized pilot of a behavioral intervention for older adults with osteoarthritis pain.
    Plumb Vilardaga JC; Kelleher SA; Diachina A; Riley J; Somers TJ
    Pilot Feasibility Stud; 2022 Aug; 8(1):164. PubMed ID: 35915512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daily Physical Activity and Functional Disability Incidence in Community-Dwelling Older Adults with Chronic Pain: A Prospective Cohort Study.
    Makino K; Lee S; Lee S; Bae S; Jung S; Shinkai Y; Shimada H
    Pain Med; 2019 Sep; 20(9):1702-1710. PubMed ID: 30561732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized phase IIa study of quantified bone scan response in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 dichloride alone or in combination with abiraterone acetate/prednisone or enzalutamide.
    Petrylak DP; Vaishampayan UN; Patel KR; Higano CS; Albany C; Dawson NA; Mehlhaff BA; Quinn DI; Nordquist LT; Wagner VJ; Siegel J; Trandafir L; Sartor O
    ESMO Open; 2021 Apr; 6(2):100082. PubMed ID: 33744812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.